Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News


seekingalpha.com > article > 4945837-kardigan-stock-funded-precision-cardiology-offers-more-than-pipeline-diversification

Kardigan: Funded Precision Cardiology Offers More Than Pipeline Diversification

1+ day, 7+ hour ago   (89+ words) Seeking Alpha - Kardigan targets genetic DCM, moderate CAVS, and post-hospitalization ASH with differentiated, biology-driven clinical programs. - KARD holds $660.7M in liquid assets, providing roughly 2–3 years of runway to achieve key clinical readouts before further funding is needed. - Upcoming 2027 data from all…...


seekingalpha.com > news > 4642250-evercommerce-boosts-share-buyback-plan-by-25m-lifting-total-to-325m

EverCommerce boosts share buyback plan by $25M, lifting total to $325M

2+ day, 20+ hour ago   (13+ words) EverCommerce boosts share buyback to $325M through 2027, funded by cash on hand....


seekingalpha.com > news > 4641871-general-dynamics-wins-184m-navy-deal-for-ngeau-production

General Dynamics wins $184M Navy deal for NGEAU production

3+ day, 20+ hour ago   (14+ words) General Dynamics wins $184.25M U.S. Navy contract for Next-Gen Electronics Attack Units through 2032....


seekingalpha.com > article > 4945223-engene-therapeutics-slashing-cash-burn-to-bring-their-asset-to-the-market

enGene Therapeutics: Slashing Cash Burn To Bring Their Asset To The Market

3+ day, 22+ hour ago   (98+ words) Seeking Alpha - enGene Therapeutics remains deeply undervalued, trading below its $3.97/share cash position despite pipeline and execution risks. - ENGN’s lead asset, detalimogene voraplasmid, faces FDA approval risk due to weak 12-month durability, but management is pursuing a surfactant cohort to…...


seekingalpha.com > news > 4641800-aquarian-purchase-of-brighthouse-financial-delayed-by-regulators-report

Aquarian purchase of Brighthouse Financial delayed by regulators - report

3+ day, 21+ hour ago   (87+ words) Seeking Alpha Aquarian's $4.1 billion deal to purchase life insurer Brighthouse Financial (BHF) has been delayed as regulators investigate the deal. Delaware’s insurance regulator questioned Aquarian founder Rudy Sahay in a closed-door meeting recently about the firm’s sources of capital backing…...


seekingalpha.com > news > 4641539-lsl-pharma-announces-cfo-transition

LSL Pharma announces CFO transition (LSL:CA:TSXV)

4+ day, 6+ hour ago   (17+ words) LSL Pharma Group announces CFO Luc Mainville’s immediate departure as the company begins a formal CFO search....


seekingalpha.com > article > 4944902-using-benchmarks-to-understand-and-measure-digital-assets

Using Benchmarks To Understand And Measure Digital Assets

4+ day, 8+ hour ago   (79+ words) Seeking Alpha - In traditional asset classes, the relationship between a strategy and its benchmark is generally well understood. In digital assets, that relationship is still developing. - Bitcoin’s performance profile differs from other digital assets - such as ecosystem layers like Ethereum…...


seekingalpha.com > news > 4641246-kioxia-chief-rules-out-deeper-ties-with-rival-sk-hynix---report

Kioxia chief rules out deeper ties with rival SK Hynix - report (SKHY:NASDAQ)

5+ day, 2+ hour ago   (59+ words) Seeking Alpha Moostocker/iStock via Getty Images Kioxia Holdings (KXIAY) (KXHCF) CEO Hiroo Ota has played down the prospect of deeper ties with South Korea’s SK Hynix (SKHY), citing antitrust concerns and the Japanese memory-chip maker’s existing manufacturing arrangements with…...


seekingalpha.com > news > 4641398-new-age-metals-plans-c1m-raise-via-a-c020-per-unit-private-placement

New Age Metals plans C$1M raise via a C$0.20-per-unit private placement

4+ day, 20+ hour ago   (59+ words) Seeking Alpha - New Age Metals (NAM:CA) announced a non-brokered private placement of 5M units at C$0.20 each for gross proceeds of C$1M, subject to TSX Venture Exchange approval. - Each unit includes one common share and half a warrant, with each…...